Attached files
file | filename |
---|---|
S-1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_s1.htm |
EX-10.6 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-6.htm |
EX-10.7 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-7.htm |
EX-10.8 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-8.htm |
EX-21.1 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex21-1.htm |
EX-10.5 - WEIKANG BIO-TECHNOLOGY GROUP CO., INC. | v175643_ex10-5.htm |
Exhibit
23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board
of Directors
of
Weikang Bio-Technology Group Company, Inc.:
We hereby consent to the use in this Registration
Statement on Form S-1 of our report dated March 1, 2009 on the audit of the consolidated balance sheet of
Weikang Bio-Technology Group Company, Inc. and subsidiaries (Formerly known as
Expedition Leasing, Inc.). as of December 31, 2008 and 2007, and the
related consolidated statements of operations and
other comprehensive income, shareholders equity (deficiency) and cash flows for
the year ended December 31, 2008 and for the period from inception (August 31, 2007) to December
31, 2007.
We also
consent to the reference to our firm under
the caption “Experts” included in this
Registration Statement.
Certified
Public Accountants
/s/ Goldman Parks Kurland Mohidin
LLP
|
|
Goldman
Parks Kurland Mohidin LLP
|
|
Encino,
California
March 25, 2010
|